Description
This straightforward guide merges scientific knowledge with actionable insights tailored for public health professionals, epidemiologists, infection control specialists, microbiologists, and those pursuing careers in these disciplines. It explores fundamental concepts related to communicable disease management and health safeguarding, outlines key syndromes, discusses infection control strategies, and details the primary services and operations within all EU countries, along with avenues for further information. Each chapter has been revised to reflect the latest developments in epidemiology, new control protocols, and administrative updates. Notably, the text has introduced fresh topics on pandemic preparedness, and the section on influenza has been expanded to encompass seasonal, avian, and pandemic strains.
Table of Contents
- Foreword
- Abbreviations
- Section 1: Introduction
- How to utilize this handbook
- Fundamental Concepts in Epidemiology and Infectious Disease Control
- Health Protection On-call
- Section 2: Common topics
- Meningitis and meningism
- Gastrointestinal infections
- Community-acquired pneumonia
- Rashes during pregnancy
- Fever and rash in children
- Health issues in returning travelers
- Sexually Transmitted Infections
- Jaundice
- Infections in immunocompromised patients
- Bloodborne viral infections
- Questions regarding vaccines
- Personal protective measures against infections
- Section 3: Diseases
- Amoebic dysentery
- Anthrax
- Bacillus cereus
- Botulism
- Brucellosis
- Burkholderia
- Campylobacter
- Chickenpox and shingles (varicella-zoster infections)
- Chikungunya
- Chlamydophila pneumoniae
- Chlamydophila psittaci
- Chlamydia trachomatis (genital)
- Cholera
- CJD and other human transmissible spongiform encephalopathies
- Clostridium difficile
- Clostridium perfringens
- Coxsackievirus infections
- Cryptosporidiosis
- Cyclosporiasis
- Cytomegalovirus
- Dengue fever
- Diphtheria
- Acute encephalitis
- Enterococci, including glycopeptide-resistant enterococci (GRE)
- Epstein-Barr virus
- Escherichia coli O157 (and other E. coli gastroenteritis)
- Giardiasis
- Gonorrhea, syphilis, and other acute STIs
- Hantavirus
- Head lice
- Helicobacter pylori
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Delta hepatitis
- Hepatitis E
- Herpes simplex
- Haemophilus influenzae type b (Hib)
- HIV
- Influenza
- Japanese B encephalitis
- Kawasaki Syndrome
- Legionellosis
- Leprosy
- Leptospirosis
- Listeria
- Lyme disease
- Malaria
- Measles
- Meningococcal infection
- Molluscum contagiosum
- MRSA (methicillin-resistant Staphylococcus aureus)
- Mumps
- Mycoplasma
- Norovirus
- Paratyphoid fever
- Parvovirus B19 (fifth disease)
- Plague
- Pneumococcal infection
- Poliomyelitis
- Q fever
- Rabies
- Relapsing fever
- Respiratory syncytial virus (RSV)
- Ringworm
- Rotavirus
- Rubella
- Salmonellosis
- Severe Acute Respiratory Syndrome (SARS)
- Scabies
- Shigella
- Smallpox
- Staphylococcal food poisoning
- Streptococcal infections
- Tetanus
- Threadworms
- Tick-borne encephalitis
- Toxocara
- Toxoplasmosis
- Tuberculosis
- Tularaemia
- Typhoid fever
- Rickettsial infections (including Typhus) Ehrlichia and Bartonella
- Vibrio parahaemolyticus
- Viral hemorrhagic fevers
- Warts and verrucae
- West Nile Virus
- Whooping cough
- Yellow fever
- Yersiniosis
- Other organisms
- Section 4: Services and organisations
- Monitoring communicable diseases
- Managing incidents and outbreaks of infectious diseases
- Infection prevention and control at the community level
- Healthcare-associated infections
- Antimicrobial resistance
- Risks related to healthcare workers
- Coordinating immunization services
- Sexual health and HIV services
- TB control services
- Travel health
- Pandemic preparedness and the Influenza A H1N1 2009 pandemic
- Non-infectious environmental risks
- Managing acute chemical emergencies
- Managing acute radiation emergencies
- Deliberate release of biological, chemical, or radiological substances
- Media relations and crisis communication
- Clinical governance and audits
- Global health
- Section 5: Communicable disease control in Europe
- WHO and International Health Regulations (IHR)
- Collaboration among EU member states
- Example of national health protection organization: England, 2010
- Austrian health protection arrangements
- Belgian health protection frameworks
- Bulgaria’s health systems
- Health protection in Cyprus
- Czech Republic’s organizational methods
- Danish health protection policies
- Estonian healthcare arrangements
- Health protection strategies in Finland
- French healthcare protections
- German health regulations
- Greek healthcare policies
- Hungarian health systems
- Icelandic health protection measures
- Irish healthcare arrangements
- Italian health mechanisms
- Latvian health services
- Lithuanian healthcare frameworks
- Luxembourg health protection policies
- Malta’s healthcare systems
- The Netherlands’ health protection
- Norwegian health policies
- Poland’s health frameworks
- Portuguese healthcare arrangements
- Romanian health systems
- Slovak healthcare measures
- Slovenian health policies
- Spanish health frameworks
- Swedish health practices
- Swiss healthcare arrangements
- United Kingdom health protections
- Appendix 1: Useful contacts and telephone numbers
- Appendix 2: Reference documents and literature
- Index
Authors
Dr. Jeremy Hawker serves as Deputy Director of Local and Regional Services at the Health Protection Agency in the UK and is a Public Health Physician along with being a consultant epidemiologist. His expertise includes the epidemiology and control of communicable diseases, with a particular focus on HIV prevention and surveillance of sexually transmitted infections. He currently heads Public Health Development at the Health Protection Agency in England and is also the Registrar of the UK Faculty of Public Health, with memberships on Scotland鈥檚 Health Protection Advisory Group and NICE’s Public Health Topic Selection Committee.
Dr. Norman Begg previously held the position of Director of Medical Affairs at GlaxoSmithKline, Uxbridge, UK.
Dr. Iain Blair is a Consultant in Communicable Diseases at the Health Protection Agency, Hampshire, UK.
Professor Ralf Reintjes holds the chair in Epidemiology and Public Health Surveillance at Hamburg University of Applied Sciences in Germany.
Professor Julius Weinberg serves as Acting Vice-Chancellor at City University in London, UK.
Professor Karl Ekdahl is the Head of the Communications Unit at the European Centre for Disease Prevention and Control and also serves as the editor of their journal.